WELCOME
- Concortis is a biotechnology company creating next generation biotherapeutics using our proprietary conjugation technologies and novel drug delivery systems.
- Concortis is dedicated to building our partnerships with other companies as well as empowering your own biotherapeutics.
Concortis Biosystems will be presenting at IBC’s Antibody-Drug Conjugates, Bispecifics & Empowered Antibodies Summit
Presenter: David Miao, President and Chief Scientific Officer
Visit www.IBCLifeSciences.com/drugdisc for conference details
Empowering
the
Biotherapeutics